Chronic Inflammatory Demyelinating Polyneuropathy

>

The NeurologyLive® Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) clinical focus page is a concentrated place for the latest information on the care and management of patients with CIDP. This page includes podcasts, videos and expert interviews, and news about the latest study and clinical trial findings, FDA actions, and clinical guideline updates.

Latest News

Kristina Allikmets, MD, PhD  (Credit: LinkedIn)
FDA Clears HyHub and HyHub Duo Devices for Easier Administration of Immune Globulin Infusion, Hyqvia

July 21st 2025

The FDA-cleared duo devices allow for a more simplified administration of the liquid medicine Hyqvia, reducing the number of steps needed to prepare for the infusion of 2 dual vial units or more.

Jean-Philippe Plançon, PhD, MSc  (Credit: EPODIN)
European Commission Approves Efgartigimod Subcutaneous Injection for Forms of CIDP

June 24th 2025

Rajiv Mallick, PhD  (Credit: LinkedIn)
Real-World Study Highlights Reduced Disability Progression of CIDP With Immunoglobulin Therapy

May 21st 2025

David Cornblath, MD  (Credit: ResearchGate)
Efficacy of CIDP Treatments Immunoglobulin 10% and Efgartigimod Compared Through Matching-Adjusted Indirect Analysis

May 19th 2025

FDA Approves Pre-Filled Syringe Administration for FcRn Modulator Efgartigimod
FDA Approves Pre-Filled Syringe Administration for FcRn Modulator Efgartigimod

April 10th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.